Researchers have invented a cheap, portable, microchip-based test for diagnosing type-1 diabetes that could speed up diagnosis and enable studies of how the disease develops.
An inexpensive, portable, microchip-based test for diagnosing type-1 diabetes could improve patient care worldwide and help researchers better understand the disease, according to the device’s inventors at the Stanford University School of Medicine.
Described in a paper published online July 13 inNature Medicine, the test employs nanotechnology to detect type-1 diabetes outside hospital settings. The handheld microchips distinguish between the two main forms of diabetes mellitus, which are both characterized by high blood-sugar levels but have different causes and treatments. Until now, making the distinction has required a slow, expensive test available only in sophisticated health-care settings. The researchers are seeking Food and Drug Administration approval of the device.
“With the new test, not only do we anticipate being able to diagnose diabetes more efficiently and more broadly, we will also understand diabetes better — both the natural history and how new therapies impact the body,” said Brian Feldman, MD, PhD, assistant professor of pediatric endocrinology and the Bechtel Endowed Faculty Scholar in Pediatric Translational Medicine. Feldman, the senior author of the paper, is also a pediatric endocrinologist at Lucile Packard Children’s Hospital Stanford.
Better testing is needed because recent changes in who gets each form of the disease have made it risky to categorize patients based on their age, ethnicity or weight, as was common in the past, and also because of growing evidence that early, aggressive treatment of type-1 diabetes improves patients’ long-term prognoses.
The Latest on: Diabetes
via Google News
The Latest on: Diabetes
- Scientists create new mouse model of permanent neonatal diabeteson August 5, 2020 at 10:38 pm
Diabetes seldom occurs in newborns--a condition known as neonatal diabetes. But when it does, it's mostly due to a mutation in a single gene such as the KCNJ11 or insulin (INS). This early-onset type ...
- Coronavirus: Type 1 diabetes fears in children amid drop in diagnoseson August 5, 2020 at 5:36 pm
Parents have been urged to be alert to type 1 diabetes after the number of children presenting with symptoms fell by almost a third during the pandemic. Between the end of March and middle of June, ...
- Woman died after 'inappropriate' diabetes care at Andover nursing homeon August 5, 2020 at 5:07 pm
A care home did not "appropriately" manage the condition of an 86-year-old diabetic who died, a coroner said. Norma Mckiver was found to have high blood sugar after a test, but instead of being ...
- Scientists establish novel 'Kuma mutant' mouse model of permanent neonatal diabeteson August 5, 2020 at 11:59 am
Diabetes seldom occurs in newborns—a condition known as neonatal diabetes. But when it does, it's mostly due to a mutation in a single gene such as the KCNJ11 or insulin (INS). This early-onset type ...
- New ACC Guidance on CVD Risk Reduction in Diabeteson August 5, 2020 at 11:29 am
The new expert consensus decision pathway incorporates emerging study data on novel diabetes therapies to reduce CVD risk among patients with diabetes.
- ACC issues updated guidance on cardiovascular risk reduction in type 2 diabetes patientson August 5, 2020 at 11:01 am
The American College of Cardiology has issued an expert consensus decision pathway (ECDP) to guide cardiovascular specialists in the initiation and monitoring of diabetes medications with the express ...
- Antibiotics may up heart disease risk in people with diabeteson August 5, 2020 at 10:15 am
"We were able to study the association between antibiotic purchases, endotoxemia and incident coronary heart disease in one of the largest cohorts of individuals with type 1 diabetes," said study ...
- Tandem Diabetes Care: Gaining Share In A Growing Marketon August 5, 2020 at 7:48 am
I have been recommending Tandem's stock for several years, and I continue to find the prospects very attractive.
- Study finds testosterone therapy can lead to remission in men with Type 2 diabeteson August 5, 2020 at 5:46 am
The findings from a recent study by a UB researcher and others could prove to be a game-changer for men with Type 2 diabetes. The single-site study, conducted over 11 years in Bremerhaven, Germany, ...
- Rare But Possible: Taking Diabetes, Cholesterol Drugs Together May Cause Toxicityon August 5, 2020 at 4:00 am
Statin toxicity or muscle weakness may occur if you take canagliflozin, a medication for treating diabetes, in combination with Crestor, used to lower cholesterol, says a new case ...
via Bing News